Cargando…
Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) has now caused over 2 million deaths worldwide and continues to expand. Currently, much is unknown about functionally neutralizing human antibody responses and durability...
Autores principales: | Markmann, Alena J., Giallourou, Natasa, Bhowmik, D. Ryan, Hou, Yixuan J., Lerner, Aaron, Martinez, David R., Premkumar, Lakshmanane, Root, Heather, van Duin, David, Napravnik, Sonia, Graham, Stephen D., Guerra, Quique, Raut, Rajendra, Petropoulos, Christos J., Wrin, Terri, Cornaby, Caleb, Schmitz, John, Kuruc, JoAnn, Weiss, Susan, Park, Yara, Baric, Ralph, de Silva, Aravinda M., Margolis, David M., Bartelt, Luther A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872367/ https://www.ncbi.nlm.nih.gov/pubmed/33564775 http://dx.doi.org/10.1101/2021.02.01.21250493 |
Ejemplares similares
-
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals
por: Markmann, Alena J., et al.
Publicado: (2021) -
Erratum for Markmann et al., “Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals”
por: Markmann, Alena J., et al.
Publicado: (2021) -
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study
por: Bartelt, Luther A., et al.
Publicado: (2022) -
Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series
por: Schwartz, Stephanie P., et al.
Publicado: (2020) -
Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center
por: Root, Heather B., et al.
Publicado: (2022)